OBI Pharma, Inc. (TPEX: 4174)

OBI Pharma Revenue

OBI Pharma had revenue of 22.98M TWD in the quarter ending September 30, 2024, with 100.24% growth. This brings the company's revenue in the last twelve months to 69.55M, up 194.24% year-over-year. In the year 2023, OBI Pharma had annual revenue of 41.55M with 781.96% growth.

• Revenue (ttm): 69.55M
• Revenue Growth: +194.24%
• P/S Ratio: 207.36
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 14.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	41.55M	36.84M	781.96%
Dec 31, 2022	4.71M	-14.06M	-74.90%
Dec 31, 2021	18.77M	-122.11M	-86.68%
Dec 31, 2020	140.89M	135.30M	2,422.13%
Dec 31, 2019	5.59M	-7.75M	-58.12%